[1] Ohya M, Negi S, Sakaguchi T, et al. Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients[J]. J Clin Endocrinol Metab, 2014, 99(10): 3873-3878.
[2] Yu L, Li H, Wang SX. Serum Magnesium and Mortality in Maintenance Hemodialysis Patients[J]. Blood Purif, 2017, 43(1-3): 31-36.
[3] Erdem E. Proton pump inhibitors use in hemodialysis patients and serum magnesium levels[J]. Int J Clin Exp Med, 2015, 8(11): 21689-21693.
[4] Rosa-Diez G, Negri AL, Crucelegui MS, et al. Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients[J]. Clin Kidney J, 2016, 9(3): 481-485.
[5] Ikee R, Toyoyama T, Endo T, et al. Impact of sevelamer hydrochloride on serum magnesium concentrations in hemodialysis patients[J]. Magnes Res, 2016, 29(4): 184-190.
[6] Hughes J, YY Chiu D, Kalra PA, et al. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease[J]. PLoS One, 2018, 13(5): e0197400.
[7] Okamoto T, Hatakeyama S, Hosogoe S, et al. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis[J]. PLoS One, 2018, 13(7): e0199160.
[8] Mikolasevic I, Milic S, Stimac D,et al. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis? [J]. Eur J Intern Med, 2016, 30: 99-103.
[9] Ago R, Shindo T, Banshodani M, et al. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study[J]. Hemodial Int, 2016, 20(4): 580-588.
[10] Nakashima A, Ohkido I, Yokoyama K, et al. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study[J]. PLoS One, 2015, 10(11): e0143656.
[11] Misra PS, Alam A, Lipman ML, et al. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study[J]. BMC Nephrol, 2015, 16: 136.
[12] Alhosaini M, Walter JS, Singh S, et al. Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors[J]. Am J Nephrol, 2014, 39(3): 204-209.
[13] Nijenhuis T, Hoenderop JG, Bindels RJ. Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia[J]. J Am Soc Nephrol, 2004, 15(3): 549-57.
[14] Oka T, Hamano T, Sakaguchi Y, et al. Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease[J]. Nephrol Dial Transplant, 2019, 34(7): 1154-1162.
[15] Maier JA. Endothelial cells and magnesium: implications in atherosclerosis[J]. Clin Sci (Lond), 2012, 122(9): 397-407.
[16] Lee S, Ryu JH, Kim SJ, et al. The Relationship between Magnesium and Endothelial Function in End-Stage Renal Disease Patients on Hemodialysis[J]. Yonsei Med J, 2016, 57(6): 1446-1453.
[17] Jo?o Matias P, Azevedo A, Laranjinha I, et al. Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients[J]. Blood Purif, 2014, 38(3-4): 244-252.
[18] Liu F, Zhang X, Qi H, et al. Correlation of serum magnesium with cardiovascular risk factors in maintenance hemodialysis patients--a cross-sectional study[J]. Magnes Res, 2013, 26(3): 100-108.
[19] Mortazavi M, Moeinzadeh F, Saadatnia M, et al. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial[J]. Eur Neurol, 2013, 69(5): 309-316.
[20] Matias PJ, Jorge C, Azevedo A, et al. Calcium Acetate/Magnesium Carbonate and Cardiovascular Risk Factors in Chronic Hemodialysis Patients[J]. Nephron, 2016, 132(4): 317-326.
[21] Pun PH, Middleton JP. Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk[J]. J Am Soc Nephrol, 2017, 28(12): 3441-3451.
[22] Dey R, Rajappa M, Parameswaran S, et al. Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk[J]. Clin Exp Nephrol, 2015, 19(6): 1054-1061.
[23] Yorifuji M, Kuragano T, Kawada S, et al. Factors associated with serum magnesium and vascular stiffness in maintenance hemodialysis patients[J]. Hemodial Int, 2018, 22(3): 342-350.
[24] Stolic RV, Jovanovic AN, Trajkovic GZ, et al. Is low magnesium a clue to arteriovenous fistula complications in hemodialysis?[J]. Int Urol Nephrol, 2016, 48(5): 773-779.
[25] Stolic RV, Trajkovic GZ, Kostic MM, et al. Factors affecting the patency of arteriovenous fistulas for hemodialysis: Single center experience[J]. Hemodial Int, 2018, 22(3): 328-334.
[26] Kanbay M, Ertuglu LA, Afsar B, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management[J]. Clin Kidney J, 2020, 13(6): 981-993.
[27] Shoji T, Tsubakihara Y, Fujii M, et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients[J]. Kidney Int, 2004, 66(3): 1212-1220.
[28] Yu J, Liu Z, Shen B, et al. Intradialytic Hypotension as an Independent Risk Factor for Long-Term Mortality in Maintaining Hemodialysis Patients: A 5-Year Follow-Up Cohort Study[J]. Blood Purif, 2018, 45(4): 320-326.
[29] Chou JA, Streja E, Nguyen DV, et al. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients[J]. Nephrol Dial Transplant, 2018, 33(1): 149-159.
[30] Pakfetrat M, Roozbeh Shahroodi J, Malekmakan L, et al . Is there an association between intradialytic hypotension and serum magnesium changes?[J]. Hemodial Int, 2010, 14(4): 492-497.
[31] Kyriazis J, Kalogeropoulou K, Bilirakis L, et al. Dialysate magnesium level and blood pressure[J]. Kidney Int, 2004, 66(3): 1221-1231.
[32] Zaher MM, Abdel-Salam M, Abdel-Salam R, et al. Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis[J]. Saudi J Kidney Dis Transpl, 2016, 27(2): 233-240.
[33] Tzanakis IP, Stamataki EE, Papadaki AN, et al. Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study[J]. Int Urol Nephrol, 2014, 46(11): 2199-2205.
[34] Ter Braake AD, Smit AE, Bos C, et al. Magnesium prevents vascular calcification in Klotho deficiency[J]. Kidney Int, 2020, 97(3): 487-501.
[35] Pasch A, Farese S, Gr?ber S, et al. Nanoparticle-based test measures overall propensity for calcification in serum[J]. J Am Soc Nephrol, 2012, 23(10): 1744-1752.
[36] Bressendorff I, Hansen D, Schou M, et al. The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial[J]. Clin J Am Soc Nephrol, 2018, 13(9): 1373-1380.
[37] Kircelli F, Peter ME, Sevinc Ok E, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner[J]. Nephrol Dial Transplant, 2012, 27(2): 514-521.
[38] Louvet L, Büchel J, Steppan S, et al. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells[J]. Nephrol Dial Transplant, 2013, 28(4): 869-878.
[39] Sonou T, Ohya M, Yashiro M, et al. Magnesium prevents phosphate-induced vascular calcification via TRPM7 and Pit-1 in an aortic tissue culture model[J]. Hypertens Res, 2017, 40(6): 562-567.
[40] Fang L, Tang B, Hou D, et al. Effect of parathyroid hormone on serum magnesium levels: the neglected relationship in hemodialysis patients with secondary hyperparathyroidism[J]. Ren Fail, 2016, 38(1): 50-56.
[41] Iguchi A, Watanabe Y, Iino N, et al . Serum magnesium concentration is inversely associated with fibroblast growth factor 23 in haemodialysis patients[J]. Nephrology (Carlton), 2014, 19(11): 667-671.
[42] Covic A, Passlick-Deetjen J, Kroczak M, et al. A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study[J]. Nephrol Dial Transplant, 2013, 28(9): 2383-2392.
[43] Sakaguchi Y, Hamano T, Wada A,et al. Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis[J]. J Am Soc Nephrol, 2018, 29(3): 991-999.
[44] Li L, Streja E, Rhee CM, et al. Hypomagnesemia and Mortality in Incident Hemodialysis Patients[J]. Am J Kidney Dis, 2015, 66(6): 1047-1055.
[45] Lacson E Jr, Wang W, Ma L, et al. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study[J]. Am J Kidney Dis, 2015, 66(6): 1056-1066.
[46] de Roij van Zuijdewijn CL, Grooteman MP, Bots ML, et al. Serum Magnesium and Sudden Death in European Hemodialysis Patients[J]. PLoS One, 2015, 10(11): e0143104.
[47] Sakaguchi Y, Fujii N, Shoji T, et al. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis[J]. Kidney Int, 2014, 85(1): 174-181.
[48] Selim GN, Spasovski G, Tozija L, et al. Hypomagnesemia and cause-specific mortality in hemodialysis patients: 5-year follow-up analysis[J]. Int J Artif Organs, 2017, 40(10): 542-549.
[49] Chen R, Xiang F, Hu J, et al. Factors associated with the elevated percentage of CD4CD69 T cells in maintained hemodialysis patients[J]. Ren Fail, 2017, 39(1): 547-554.
[50] Mizuiri S, Nishizawa Y, Yamashita K, et al. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients[J]. Int Urol Nephrol, 2019, 51(6): 1043-1052.
[51] Okazaki H, Ishimura E, Okuno S, et al. Significant positive relationship between serum magnesium and muscle quality in maintenance hemodialysis patients[J]. Magnes Res, 2013, 26(4): 182-187.
[52] Yu L, Song J, Lu X, et al. Association between Serum Magnesium and Erythropoietin Responsiveness in Hemodialysis Patients: A Cross-Sectional Study[J]. Kidney Blood Press Res, 2019, 44(3): 354-361.
[53] Bansal AD, Negoianu D, Warburton KM. An Unusual yet "Mg"nificent Indication for Hemodialysis[J]. Semin Dial, 2016, 29(3): 247-250.
[54] Yoon HE, Kim YW, Ha KS, et al. Hypermagnesemia accompanied with colonic perforation in a hemodialysis patient[J]. Yonsei Med J, 2013, 54(3): 797-800.
[55] Schmaderer C, Braunisch MC, Suttmann Y, et al. Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study[J]. Nutrients, 2017, 9(9): 926.
[56] Alhosaini M, Leehey DJ. Magnesium and Dialysis: The Neglected Cation[J]. Am J Kidney Dis, 2015, 66(3): 523-531.
